Cargando…

P-selectin genotype is associated with the development of cancer cachexia

The variable predisposition to cachexia may, in part, be due to the interaction of host genotype. We analyzed 129 single nucleotide polymorphisms (SNPs) in 80 genes for association with cachexia based on degree of weight loss (>5, >10, >15%) as well as weight loss in the presence of systemi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tan, Benjamin H L, Fladvad, Torill, Braun, Theodore P, Vigano, Antonio, Strasser, Florian, Deans, D A Christopher, Skipworth, Richard J E, Solheim, Tora S, Damaraju, Sambasivarao, Ross, James A, Kaasa, Stein, Marks, Daniel L, Baracos, Vickie E, Skorpen, Frank, Fearon, Kenneth C H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	WILEY-VCH Verlag 2012
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3443952/ https://www.ncbi.nlm.nih.gov/pubmed/22473907 http://dx.doi.org/10.1002/emmm.201200231

Ejemplares similares

Is there a genetic cause of appetite loss?—an explorative study in 1,853 cancer patients
por: Solheim, Tora S., et al.
Publicado: (2012)

Is there a genetic cause for cancer cachexia? – a clinical validation study in 1797 patients
por: Solheim, T S, et al.
Publicado: (2011)

New genetic signatures associated with cancer cachexia as defined by low skeletal muscle index and weight loss
por: Johns, Neil, et al.
Publicado: (2016)

A prospective study examining cachexia predictors in patients with incurable cancer
por: Vagnildhaug, Ola Magne, et al.
Publicado: (2019)

The applicability of a weight loss grading system in cancer cachexia: a longitudinal analysis
por: Vagnildhaug, Ola Magne, et al.
Publicado: (2017)

Differentially expressed alternatively spliced genes in skeletal muscle from cancer patients with cachexia
por: Narasimhan, Ashok, et al.
Publicado: (2017)

Small RNAome profiling from human skeletal muscle: novel miRNAs and their targets associated with cancer cachexia
por: Narasimhan, Ashok, et al.
Publicado: (2017)

Pitfalls in defining and quantifying cachexia
por: Baracos, Vickie E.
Publicado: (2011)

Physical function endpoints in cancer cachexia clinical trials: Systematic Review 1 of the cachexia endpoints series
por: McDonald, James, et al.
Publicado: (2023)

Power Comparisons and Clinical Meaning of Outcome Measures in Assessing Treatment Effect in Cancer Cachexia: Secondary Analysis From a Randomized Pilot Multimodal Intervention Trial
por: Balstad, Trude R., et al.
Publicado: (2021)

A randomized phase II feasibility trial of a multimodal intervention for the management of cachexia in lung and pancreatic cancer
por: Solheim, Tora S., et al.
Publicado: (2017)

Deterioration in Muscle Mass and Physical Function Differs According to Weight Loss History in Cancer Cachexia
por: Stene, Guro Birgitte, et al.
Publicado: (2019)

The N-Terminally Truncated µ3 and µ3-Like Opioid Receptors Are Transcribed from a Novel Promoter Upstream of Exon 2 in the Human OPRM1 Gene
por: Andersen, Sonja, et al.
Publicado: (2013)

Altered cancer cell metabolism and cachexia: Calculating the energetic cost of cancer
por: Friesen, Douglas, et al.
Publicado: (2014)

Central nervous system inflammation induces muscle atrophy via activation of the hypothalamic–pituitary–adrenal axis
por: Braun, Theodore P., et al.
Publicado: (2011)

Modeling the energetic cost of cancer as a result of altered energy metabolism: implications for cachexia
por: Friesen, Douglas E., et al.
Publicado: (2015)

Concurrent evolution of cancer cachexia and heart failure: bilateral effects exist
por: Kazemi-Bajestani, Seyyed M. R., et al.
Publicado: (2014)

Cancer cachexia associates with a systemic autophagy-inducing activity mimicked by cancer cell-derived IL-6 trans-signaling
por: Pettersen, Kristine, et al.
Publicado: (2017)

Intramyocellular lipid droplets increase with progression of cachexia in cancer patients
por: Stephens, Nathan A., et al.
Publicado: (2011)

Identification and management of cancer cachexia in patients: Assessment of healthcare providers' knowledge and practice gaps
por: Baracos, Vickie E., et al.
Publicado: (2022)

Trajectory of health-related quality of life during the last year of life in patients with advanced non-small–cell lung cancer
por: Kristensen, Are, et al.
Publicado: (2022)

Effects of Sample Size on Differential Gene Expression, Rank Order and Prediction Accuracy of a Gene Signature
por: Stretch, Cynthia, et al.
Publicado: (2013)

An invitation to the 2nd Cancer Cachexia Conference, Montréal, Canada
por: Guttridge, Denis, et al.
Publicado: (2014)

Genetic and Non-genetic Factors Associated With Constipation in Cancer Patients Receiving Opioids
por: Laugsand, Eivor A, et al.
Publicado: (2015)

Perspectives of Health Care Professionals on Multimodal Interventions for Cancer Cachexia
por: Amano, Koji, et al.
Publicado: (2022)

Diagnostic criteria for cancer cachexia: reduced food intake and inflammation predict weight loss and survival in an international, multi‐cohort analysis
por: Martin, Lisa, et al.
Publicado: (2021)

Evaluating potential biomarkers of cachexia and survival in skeletal muscle of upper gastrointestinal cancer patients
por: Stephens, Nathan A, et al.
Publicado: (2015)

Clinical and biological characterization of skeletal muscle tissue biopsies of surgical cancer patients
por: Anoveros‐Barrera, Ana, et al.
Publicado: (2019)

Reduced LDL-Cholesterol and Reduced Total Cholesterol as Potential Indicators of Early Cancer in Male Treatment-Naïve Cancer Patients With Pre-cachexia and Cachexia
por: Zwickl, Hannes, et al.
Publicado: (2020)

A systematic review on the role of vitamins, minerals, proteins, and other supplements for the treatment of cachexia in cancer: a European Palliative Care Research Centre cachexia project
por: Mochamat,, et al.
Publicado: (2016)

Neuromuscular junctions are stable in patients with cancer cachexia
por: Boehm, Ines, et al.
Publicado: (2020)

Request for regulatory guidance for cancer cachexia intervention trials
por: Fearon, KCH, et al.
Publicado: (2015)

Increased expression of phosphorylated forms of RNA-dependent protein kinase and eukaryotic initiation factor 2α may signal skeletal muscle atrophy in weight-losing cancer patients
por: Eley, H L, et al.
Publicado: (2008)

Using transcriptomics to identify and validate novel biomarkers of human skeletal muscle cancer cachexia
por: Stephens, Nathan A, et al.
Publicado: (2010)

The Challenges and Opportunities in the Clinical Application of Noncoding RNAs: The Road Map for miRNAs and piRNAs in Cancer Diagnostics and Prognostics
por: Krishnan, Preethi, et al.
Publicado: (2018)

Understanding Cancer Cachexia and Its Implications in Upper Gastrointestinal Cancers
por: Brown, Leo R., et al.
Publicado: (2022)

Cancer cachexia in adult patients: ESMO Clinical Practice Guidelines(☆)
por: Arends, J., et al.
Publicado: (2021)

Psoas as a sentinel muscle for sarcopenia: a flawed premise
por: Baracos, Vickie E.
Publicado: (2017)

Practical multimodal care for cancer cachexia
por: Maddocks, Matthew, et al.
Publicado: (2016)

Genetic variation in the Catechol-O-Methyltransferase (COMT) gene and morphine requirements in cancer patients with pain
por: Rakvåg, Trude T, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_4vajmq0o9an392dfjuqjn3iaro